Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2008

01-04-2008 | Original Article

Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer

Authors: Nozomu Fuse, Toshihiko Doi, Atsushi Ohtsu, Tomonori Yano, Yasuo Hamamoto, Keiko Minashi, Makoto Tahara, Manabu Muto, Masahiro Asaka, Shigeaki Yoshida

Published in: International Journal of Clinical Oncology | Issue 2/2008

Login to get access
Metadata
Title
Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer
Authors
Nozomu Fuse
Toshihiko Doi
Atsushi Ohtsu
Tomonori Yano
Yasuo Hamamoto
Keiko Minashi
Makoto Tahara
Manabu Muto
Masahiro Asaka
Shigeaki Yoshida
Publication date
01-04-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0737-z

Other articles of this Issue 2/2008

International Journal of Clinical Oncology 2/2008 Go to the issue

Case Report

Small cell carcinoma of the ovary: clinical and biological study

Original Article

5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil

Review Article

The role of cancer registries in cancer control

From the Asco-Jsco Joint Symposium

Chemoradiotherapy for unresectable pancreatic cancer

Review Article

Current activities and future directions of the cancer registration system in Japan

Original Article

Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits